Lower Extremity Peripheral Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Report Overview

The Lower Extremity Peripheral Atherectomy Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The US

·       Global

·       China

·       Israel

Key Segments ·       Peripheral Laser Atherectomy

·       Peripheral Rotational Atherectomy

·       Peripheral Directional Atherectomy

Key Regulatory Paths ·       510(k)

·       NMPA

·       PMA

Leading Companies ·       Acotec Scientific Holdings Ltd

·       ArioMedica Ltd.

·       Avinger Inc

·       Boston Scientific Corp

·       Cardiovascular Systems Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Segments

A few of the key segments in the Lower Extremity Peripheral Atherectomy Devices pipeline market are the Peripheral Laser Atherectomy, Peripheral Rotational Atherectomy, and Peripheral Directional Atherectomy. As of May 2024, Peripheral Laser Atherectomy accounted for the highest number of Lower Extremity Peripheral Atherectomy Devices pipeline products.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Segments, 2024 (%)

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Lower Extremity Peripheral Atherectomy Devices Pipeline Market

Download a Free Report Sample

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Segmentation by Territories

A few of the key territories with the Lower Extremity Peripheral Atherectomy Devices pipeline market are the US, Global, China, and Israel among others. As of May 2024, the US accounted for the highest number of Lower Extremity Peripheral Atherectomy Devices pipeline products.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Territories, 2024 (%)

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Lower Extremity Peripheral Atherectomy Devices Pipeline Market

Download a Free Report Sample

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the Lower Extremity Peripheral Atherectomy Devices pipeline products market are PMA, 510(k), and NMPA. As of May 2024, 510(k) was the most followed pathway for pipeline products in the Lower Extremity Peripheral Atherectomy Devices market.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Lower Extremity Peripheral Atherectomy Devices Pipeline Market

Download a Free Report Sample

Lower Extremity Peripheral Atherectomy Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the Lower Extremity Peripheral Atherectomy Devices pipeline market are Acotec Scientific Holdings Ltd, ArioMedica Ltd., Avinger Inc., Boston Scientific Corp, and Cardiovascular Systems Inc. among others.

Avinger Inc: Avinger designs, manufactures, and sells image-guided, catheter-based systems to treat patients with peripheral artery disease (PAD). It develops products based on its Lumivascular platform, an intravascular image-guided system that provides real-time visualization of the inside of the artery during PAD treatment by using optical coherence tomography (OCT). The company’s product portfolio includes the Lightbox imaging console, the Ocelot family of catheters, and Pantheris, an image-guided atherectomy device. Avinger sells a suite of products in the US and selected international markets. Its products are used by physicians including vascular surgeons, interventional cardiologists, and interventional radiologists to treat patients with PAD. Avinger is headquartered in Redwood City, California, the US.

Boston Scientific Corp: Boston Scientific is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world. The company has manufacturing facilities in the US, Ireland, Costa Rica, Brazil, Malaysia and Puerto Rico. It sells products directly and also through a network of distributors and dealers in Europe, the Middle East, Africa, Asia Pacific, and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Companies, 2024

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Lower Extremity Peripheral Atherectomy Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Segments Outlook (2024)

  • Peripheral Laser Atherectomy
  • Peripheral Rotational Atherectomy
  • Peripheral Directional Atherectomy

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Territories Outlook (2024)

  • The US
  • Global
  • China
  • Israel

Lower Extremity Peripheral Atherectomy Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • PMA

Scope

This report provides:

  • Extensive coverage of the Lower Extremity Peripheral Atherectomy Devices under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Lower Extremity Peripheral Atherectomy Devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Lower Extremity Peripheral Atherectomy Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Acotec Scientific Holdings Ltd
ArioMedica Ltd.
Avinger Inc
Boston Scientific Corp
Cardiovascular Systems Inc
Covidien Ltd
Eximo Medical Ltd
GlobeStar Therapeutics Corp
OrbusNeich
Terumo Interventional Systems
Terumo Medical Corp

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Lower Extremity Peripheral Atherectomy Devices Overview

  • 3 Products under Development

    • 3.1 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Stage of Development
    • 3.2 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Segment
    • 3.3 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Territory
    • 3.4 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Regulatory Path
    • 3.5 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Estimated Approval Date
    • 3.6 Lower Extremity Peripheral Atherectomy Devices – Ongoing Clinical Trials

  • 4 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products under Development by Companies

    • 4.1 Lower Extremity Peripheral Atherectomy Devices Companies – Pipeline Products by Stage of Development
    • 4.2 Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Stage of Development

  • 5 Lower Extremity Peripheral Atherectomy Devices Companies and Product Overview

    • 5.1 Acotec Scientific Holdings Ltd Company Overview

      • 5.1.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 ArioMedica Ltd. Company Overview

      • 5.2.1 ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Avinger Inc Company Overview

      • 5.3.1 Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Boston Scientific Corp Company Overview

      • 5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Cardiovascular Systems Inc Company Overview

      • 5.5.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Covidien Ltd Company Overview

      • 5.6.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Eximo Medical Ltd Company Overview

      • 5.7.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 GlobeStar Therapeutics Corp Company Overview

      • 5.8.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 OrbusNeich Company Overview

      • 5.9.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Terumo Interventional Systems Company Overview

      • 5.10.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Terumo Medical Corp Company Overview

      • 5.11.1 Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Lower Extremity Peripheral Atherectomy Devices- Recent Developments
  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Stage of Development 7

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Segment 8

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Territory 9

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Regulatory Path 10

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Estimated Approval Date 11

Lower Extremity Peripheral Atherectomy Devices – Ongoing Clinical Trials 12

Lower Extremity Peripheral Atherectomy Devices Companies – Pipeline Products by Stage of Development 13

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Stage of Development 14

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 15

Peripheral Rotational Atherectomy Device – Product Status 15

Peripheral Rotational Atherectomy Device – Product Description 15

ArioMedica Ltd. Pipeline Products & Ongoing Clinical Trials Overview 16

Atherectomy Device – Product Status 16

Atherectomy Device – Product Description 16

Avinger Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Wolverine Catheter – Product Status 17

Wolverine Catheter – Product Description 17

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 18

Peripheral Atherectomy Device – Product Status 18

Peripheral Atherectomy Device – Product Description 18

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Mixed Plaque Atherectomy System – Product Status 19

Mixed Plaque Atherectomy System – Product Description 19

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Gen II SilverHawk – Product Status 20

Gen II SilverHawk – Product Description 20

Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

AURYON Atherectomy System – CAD – Product Status 21

AURYON Atherectomy System – CAD – Product Description 21

AURYON Atherectomy System – Venous Disease – Product Status 22

AURYON Atherectomy System – Venous Disease – Product Description 22

GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Atherectomy Catheter II – Product Status 23

Atherectomy Catheter II – Product Description 23

OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 24

Large Vessel ATK Mixed Plaque – Product Status 24

Large Vessel ATK Mixed Plaque – Product Description 24

Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 25

Atherectomy Device – Product Status 25

Atherectomy Device – Product Description 25

Terumo Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Kaitoh Atherectomy System – Product Status 26

Kaitoh Atherectomy System – Product Description 26

Terumo Medical Corp – Ongoing Clinical Trials Overview 27

Kaitoh Atherectomy System – Kaitoh Atherectomy System: Peripheral Artery Revascularization of Stenotic/Restenotic Disease Using the Atherectomy System in the Peripheral Arteries 28

Glossary 34

Figures

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Stage of Development 7

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Segment 8

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Territory 9

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Regulatory Path 10

Lower Extremity Peripheral Atherectomy Devices – Pipeline Products by Estimated Approval Date 11

Lower Extremity Peripheral Atherectomy Devices – Ongoing Clinical Trials 12

Frequently asked questions

Lower Extremity Peripheral Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Lower Extremity Peripheral Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Lower Extremity Peripheral Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Lower Extremity Peripheral Atherectomy Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.